Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Positive interim phase III data released for lenzilumab in hospitalized patients with COVID-19

Nov. 9, 2020

CAN-COVID trial of canakinumab in patients with COVID-19 pneumonia and CRS misses endpoints

Nov. 6, 2020

Phase II extension study of vebicorvir in HBV does not achieve meaningful SVR rates

Nov. 6, 2020

Phase I data presented for iCo-019, novel oral formulation of amphotericin B

Nov. 6, 2020

Preclinical data on EBS-LASV vaccine presented

Nov. 6, 2020

Acurx reports phase IIa data on ibezapolstat in C. difficile infection

Nov. 6, 2020

PK and safety data for nacubactam in combination with beta-lactams

Nov. 5, 2020

Hoth outlines progress within COVID-19 pipeline

Nov. 5, 2020

Aligos begins first-in-human trial of ALG-000184 for chronic hepatitis B

Nov. 4, 2020

AT-752 improves survival in mouse model of dengue infection

Nov. 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...